Sambasiva Reddy

Title: The Innovative Contributions of Sambasiva Reddy

Introduction

Sambasiva Reddy is a notable inventor based in Bengaluru, India. He has made significant contributions to the field of pharmaceuticals, particularly in the development of compounds that target adenosine receptors. His work is characterized by a commitment to advancing medical science through innovative research and development.

Latest Patents

Sambasiva Reddy holds a patent for "Diaminopyrazolo[1,5-a]pyrimidine-6-carbonitrile compounds as adenosine 2A receptor and adenosine 2B receptor antagonist." This patent describes a compound of Formula I or its pharmaceutically acceptable salts, complexes, hydrates, solvates, tautomers, polymorphs, stereoisomers, and racemates. The compounds of Formula I act as antagonists to adenosine receptors, providing a potential therapeutic avenue for various medical conditions. The patent also outlines a process for the preparation of these compounds and their pharmaceutical compositions.

Career Highlights

Sambasiva Reddy is currently associated with Bugworks Research, Inc., where he continues to push the boundaries of pharmaceutical innovation. His work at Bugworks Research focuses on developing novel therapeutic agents that can address unmet medical needs.

Collaborations

Some of his notable coworkers include Shahul Hameed Peer Mohamed and Radha Nandishaiah. Their collaborative efforts contribute to the dynamic research environment at Bugworks Research, fostering innovation and discovery.

Conclusion

Sambasiva Reddy's contributions to the field of pharmaceuticals through his innovative patents and collaborative work exemplify the impact of dedicated inventors in advancing medical science. His ongoing research promises to lead to significant advancements in therapeutic options for patients.